STOCKHOLDERS’ DEFICIT - Schedule of Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Number of Shares
Beginning balance (in shares)	2,257,000
Cancellation of common stock in connection with emergence (in shares)		(22,575,000)
Issuance of new common stock in connection with emergence (in shares)		2,257,000
Granted (in shares)	0	0
Exercised (in shares)	0
Forfeited or cancelled (in shares)	(1,888,000)
Expired (in shares)	0
Ending balance (in shares)	369,000	2,257,000
Options expected to vest (in shares)	0
Options exercisable (in shares)	369,000
Weighted- Average Exercise Price
Beginning balance, weighted average exercise price (in dollars per share)	$ 88.84
Cancellation of common stock in connection with emergence (in dollars per share)		$ 8.88
Issuance of new common stock in connection with emergence (in dollars per share)		88.84
Granted, weighted average exercise price (in dollars per share)	0
Exercised, weighted average exercise price (in dollars per share)	0
Forfeited or cancelled, weighted average exercise price (in dollars per share)	94.09
Expired, weighted average exercise price (in dollars per share)	0
Ending balance, weighted average exercise price (in dollars per share)	62.12	$ 88.84
Options expected to vest, weighted average exercise price (in dollars per share)	127.39
Options exercisable, weighted average exercise price (in dollars per share)	$ 61.61
Options remaining contractual term	3 years 7 months 6 days	6 years 10 months 24 days
Options expected to vest, remaining contractual term	3 years 2 months 12 days
Options exercisable, remaining contractual term	3 years 7 months 6 days
Options aggregate intrinsic value	$ 372	$ 0
Options expected to vest, aggregate intrinsic value	0
Options exercisable, aggregate intrinsic value	$ 372
Previously Reported
Number of Shares
Beginning balance (in shares)	22,575,000
Ending balance (in shares)		22,575,000
Weighted- Average Exercise Price
Beginning balance, weighted average exercise price (in dollars per share)	$ 8.88
Ending balance, weighted average exercise price (in dollars per share)		$ 8.88